Aequus Pharmaceuticals (AQS) News Today C$0.0050 0.00 (-37.50%) As of 04/25/2025 Add Compare Share Share Headlines Stock AnalysisChartEarningsBuy This Stock AQS Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Aequus Pharmaceuticals: Top 10 Undervalued Healthcare Sector Stocks on TSX-V (AQS)January 22, 2025 | theglobeandmail.comAequus Pharmaceuticals Reports Revenue Growth Amid RestructuringNovember 9, 2024 | markets.businessinsider.comAequus Pharmaceuticals Inc. (AQSZF)September 5, 2024 | finance.yahoo.comAequus Pharmaceuticals Inc (AQS)August 3, 2024 | investing.comClosing Bell: Aequus Pharmaceuticals Inc down on Friday (AQS)July 23, 2024 | theglobeandmail.comAequus Pharmaceuticals Full Year 2023 Earnings: CA$0.022 loss per share (vs CA$0.024 loss in FY 2022)May 2, 2024 | finance.yahoo.comAQS:CA Aequus Pharmaceuticals Inc.April 19, 2024 | seekingalpha.comZoomd Technologies: Top 10 Undervalued Growth Stocks on TSX-V (ZOMD)February 23, 2024 | theglobeandmail.comAequus Pharmaceuticals: Top 10 Undervalued Drug Manufacturers Industry Stocks (AQS)February 18, 2024 | theglobeandmail.comAequus Pharmaceuticals Inc AQSDecember 12, 2023 | morningstar.comMAequus Pharmaceuticals reports Q3 resultsNovember 30, 2023 | msn.comClosing Bell: Aequus Pharmaceuticals Inc up on Thursday (AQS)October 18, 2023 | theglobeandmail.comClosing Bell: Aequus Pharmaceuticals Inc flat on Thursday (AQS)October 7, 2023 | theglobeandmail.comClosing Bell: Aequus Pharmaceuticals Inc flat on Tuesday (AQS)October 5, 2023 | theglobeandmail.comClosing Bell: Aequus Pharmaceuticals Inc flat on Friday (AQS)September 29, 2023 | theglobeandmail.comClosing Bell: Aequus Pharmaceuticals Inc flat on Wednesday (AQS)September 28, 2023 | theglobeandmail.comAequus Pharmaceuticals: Aequus Reports Second Quarter 2023 Financial Highlights and General UpdateAugust 30, 2023 | finanznachrichten.deAequus Reports Second Quarter 2023 Financial Highlights and General UpdateAugust 29, 2023 | markets.businessinsider.comClosing Bell: Aequus Pharmaceuticals Inc up on Wednesday (AQS)August 25, 2023 | theglobeandmail.comAequus Announces Zimed PF Now Available in CanadaAugust 24, 2023 | finance.yahoo.comAequus Announces Zimed PF Website LaunchAugust 22, 2023 | finance.yahoo.comAequus Pharmaceutical Canada Announces a Pause in Sales of Evolve Intensive Eyedrops and Gel in CanadaAugust 18, 2023 | finance.yahoo.comAequus Announces Financing to Support Launch of Zimed Preservative Free (Bimatoprost 0.03%)July 6, 2023 | benzinga.comAQS.V - Aequus Pharmaceuticals Inc.June 7, 2023 | ca.finance.yahoo.comAequus Pharmaceuticals: Aequus Provides General Update and First Quarter 2023 Financial HighlightsMay 31, 2023 | finanznachrichten.deAequus Provides General Update and First Quarter 2023 Financial HighlightsMay 30, 2023 | finance.yahoo.comAequus Provides General Update and Fiscal 2022 Financial ResultsMay 1, 2023 | finance.yahoo.comAequus Grants Stock OptionsApril 19, 2023 | finance.yahoo.comAequus Announces Financing to Support Launch of Zimed Preservative Free (Bimatoprost 0.03%) and Board UpdateApril 5, 2023 | finance.yahoo.comAequus Pharmaceuticals Inc. (AQS.V)March 26, 2023 | finance.yahoo.comAequus Announces Health Canada Notice of Compliance (NOC) for Zimed® Preservative Free (Bimatoprost 0.03%)December 20, 2022 | finance.yahoo.comAequus Pharmaceuticals Third Quarter 2022 Earnings: CA$0.004 loss per share (vs CA$0.003 loss in 3Q 2021)December 3, 2022 | yahoo.comAequus Pharmaceuticals: Aequus Reports Third Quarter 2022 Financial HighlightsNovember 30, 2022 | finanznachrichten.deAequus Reports Third Quarter 2022 Financial HighlightsNovember 30, 2022 | finance.yahoo.comAequus Announces Sandoz Contract Expiry at Year End and Expected Health Canada Approval for Zimed® PF (Preservative Free)November 29, 2022 | finance.yahoo.comAequus Pharmaceuticals IncOctober 9, 2022 | reuters.comAequus Pharmaceuticals reports Q2 resultsAugust 30, 2022 | seekingalpha.comAequus Reports Second Quarter 2022 Financial Highlights and General UpdateAugust 29, 2022 | finance.yahoo.comIIROC Trading Resumption - AQSJuly 13, 2022 | finance.yahoo.comAequus Resumes Trading on TSX Venture ExchangeJuly 13, 2022 | finance.yahoo.comAequus Provides General Update and Reports Record 2021 Financial ResultsJuly 1, 2022 | financialpost.comFAequus Provides Update on Delay in Filing Annual Financial StatementsMay 6, 2022 | stockhouse.comIIROC Trading Halt - AQS.WTMay 2, 2022 | finance.yahoo.comIIROC Trading Halt - AQS.DBMay 2, 2022 | finance.yahoo.comAequus Announces Short Term LoanMay 2, 2022 | stockhouse.comAequus Announces Director ResignationApril 22, 2022 | benzinga.comSandoz and Aequus Agree to 1-Year Extension on Vistitan in CanadaJanuary 11, 2022 | finance.yahoo.comAequus Announces Canadian Filing of NDS for Preservative-Free Glaucoma MedicationJanuary 6, 2022 | finance.yahoo.comIs Aequus Pharmaceuticals (CVE:AQS) Weighed On By Its Debt Load?November 5, 2021 | ca.finance.yahoo.comAequus Reports Third Quarter 2021 Financial HighlightsNovember 3, 2021 | apnews.comA Get Aequus Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AQS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AQS Media Mentions By Week AQS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AQS News Sentiment▼0.000.97▲Average Medical News Sentiment AQS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AQS Articles This Week▼00▲AQS Articles Average Week Get the Latest News and Ratings for AQS and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Aequus Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies DHT.UN News Today PWR News Today BHC News Today TLRY News Today CRON News Today GUD News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (CVE:AQS) was last updated on 8/27/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aequus Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aequus Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access